Antimicrobial Resistance in Human Oral and Intestinal Anaerobic Microfloras

Size: px
Start display at page:

Download "Antimicrobial Resistance in Human Oral and Intestinal Anaerobic Microfloras"

Transcription

1 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1993, p Vol. 37, No /93/ $02.00/0 Copyright X 1993, American Society for Microbiology Antimicrobial Resistance in Human Oral and Intestinal Anaerobic Microfloras CHRISTINA A. STARK,' CHARLOTTA EDLUND,1 SVANTE SJOSTEDT,2 GUN KRISTENSEN,3 AND CARL ERIK NORD"* Departments ofmicrobiology' and Surgery,2 Huddinge University Hospital, Karolinska Institute, Huddinge, and Axelsberg Public Health Centre, Stockholm, 3 Sweden Received 22 June 1992/Accepted 25 May 1993 In the present study we determined the resistance patterns of anaerobic bacteria from human saliva and stool specimens and investigated whether there were significant differences in resistance between outpatients and hospitalized patients, regardless of whether they had received antimicrobial agents. No bacterial strains resistant to ampicillin, piperacillin, cefoxitin, cefuroxime, imipenem, clindamycin, doxycycline, chloramphenicol, or metronidazole were isolated from the saliva samples. However, resistance to ampicillin, cefoxitin, and cefuroxime was found in strains from 70%o of the fecal samples (mainly Bacteroides thetaiotaomicron, Clostridium innocuum, and Bacteroides ovatus). Resistance to both ampicillin and cefuroxime was frequently found in 19%o of the isolated strains (mainly B. thetaiotaomicron, B. ovatus, and Bacteroides vulgatus). No strains that were resistant to imipenem, chloramphenicol, or metronidazole were found. Hospitalization and/or intake of antimicrobial agents was associated with an increase in the relative number of resistant anaerobic intestinal bacteria. The percentage of resistant anaerobic strains encountered, compared with the total number of anaerobic bacteria in the normal fecal microflora, was between 5.2 and 14.8%, with the lower value associated with the outpatient group. Two-thirds of the resistant strains from this group had a relative frequency of less than 1% of the total anaerobic flora, while one-third of the strains were present at a level of greater than 1%; for the hospitalized patients, two-thirds of the strains were present at a level of greater than 1%, and one-third of the strains were present at a level of less than 1% (P < 0.001). Patients who had received antimicrobial agents for 6 days or more (n = ) had an average of 1.6 resistant anaerobic strains each, while patients treated for 3 to 5 days (n = ) had a mean number of 0.87 resistant strains each (P < 0.05). The normal human oral and intestinal microfloras are huge potential reservoirs of resistant organisms which may cause infections in other sites of the body. Bacteria from the intestinal microflora dominate as causative agents in postoperative infections, and resistance among them may seriously complicate the prophylaxis and treatment of intra-abdominal infections (12). A correlation between drug consumption and the emergence of bacterial drug resistance in the normal intestinal microflora of outpatients and hospitalized patients has been reported (1, 6, 8, 19). Those investigations have mainly focused on aerobic bacteria; it has been shown that administration of ampicillin or tetracycline significantly increases the number of resistant gram-negative aerobic microorganisms in the fecal flora, while other agents such as amoxicillin, cefuroxime, imipenem, and metronidazole have been shown to have no impact on the development of resistance patterns (12, 18). Most of the anaerobic microorganisms that cause clinical infections come from the normal oropharyngeal and gastrointestinal microfloras. Since anaerobic bacteria outnumber the aerobic bacteria both in the oral cavity (0:1) and in the intestinal tract (1,000:1), it is of interest to investigate the antimicrobial resistance patterns in the normal anaerobic microfloras from both outpatient and hospitalized individuals Ṫhe aim of the present study was to investigate the resistance patterns in the normal oral and intestinal microfloras of outpatients with no recent history of antimicrobial * Corresponding author treatment compared with those in the microfloras of hospitalized patients with and without a recent history of antimicrobial treatment. An effort was made to provide quantitative comparisons of specific drug-resistant populations in all three study groups. MATERIALS AND METHODS Patients. From October 1990 until October 1991, saliva and fecal samples were collected from 150 patients who were equally distributed in the three groups. Group A consisted of 50 patients who visited an outpatient department, who were not treated with antimicrobial agents, and who had not stayed in the hospital during the previous 6 months (31 female and 19 male patients; mean age, 58 years; age range, 24 to 84 years). Group B was made up of 50 inpatients at the Department of Surgery, Huddinge University Hospital, who had not been treated with antimicrobial agents during the previous 6 months ( female and male patients; mean age, 66 years; age range, 27 to 87 years). The mean number of days in hospital was 15.6 range, 6 to 1 days). Group C consisted of 50 inpatients at the Department of Surgery, Huddinge University Hospital, who had been treated with various antimicrobial agents for at least 3 days during the previous 2 weeks and whose treatment was terminated 3 days before the sampling (23 female and 27 male patients; mean age, 60 years; age range, 19 to 86 years). The mean hospital stay was 16.0 days (range, 6 to 90 days), and the mean time of antimicrobial treatment was 5 days (range, 3 to 19 days). For this group, the dominant antimicrobial regimen was cefuroxime (36 patients), and 31 patients in that group were treated with cefuroxime in combination with metron- Downloaded from on November 9, 18 by guest

2 1666 STARK ET AL. idazole. The following other antimicrobial regimens were used as single or combination therapy: trimethoprim (seven patients), sulfonamide (six patients), imipenem (three patients), cefadroxil (two patients), phenoxymethylpenicillin, benzylpenicillin, ampicillin, cloxacillin, pivampicillin, and amdinocillin (pivmecillinam), tobramycin, cefoxitin, aztreonam, doxycyline, metronidazole, and gentamicin (one patient each). There was no significant difference between the three patient groups by sex or age distribution. Sample collection and processing. Saliva and fecal samples from each patient were collected into sterile plastic containers and were immediately transported to the laboratory, where they were frozen at -70 C until they were processed. Processing of saliva samples. A sterile swab was soaked in the saliva and was rinsed in 1 ml of prereduced peptone yeast glucose medium (PYG). Aliquots of 0.1 ml of the resulting suspension were rapidly inoculated onto nine freshly prepared PDM-agar plates (AB Biodisk, Solna, Sweden) containing 5% defibrinated horse blood and nine different antimicrobial agents at defined concentrations. The antimicrobial agents and the corresponding breakpoints used were as follows: ampicillin (Astra, Sodertalje, Sweden),.32 p,g/ml; piperacillin, (Lederle),.64,ug/ml; cefoxitin and imipenem (Merck Sharp & Dohme International, Rahway, N.J.),.32,ug/ml; cefuroxime (Glaxo Ltd., Greenford, Middlesex, United Kingdom),.32,ug/ml; clindamycin (Upjohn),.16,g/ml; doxycycline (Pfizer, Brussels, Belgium),.8,ig/ml; chloramphenicol (Parke-Davis Pharmaceutical Research Division, Warner Lambert Company, Ann Arbor, Mich.).32 jig/ml; and metronidazole (Rhone-Poulenc Rorer, Birkeroed, Denmark),.32 p,g/ml. All agar plates contained gentamicin (16 jig/ml; Roussel Laboratories Ltd., Swindon, United Kingdom) in order to prevent growth of aerobic microorganisms. This concentration of gentamicin was chosen since it inhibits the growth of most aerobic and facultatively anaerobic bacteria without affecting the growth of anaerobic bacteria. Three agar plates containing only gentamicin and blood served as controls in order to quantify the total number of anaerobic bacteria and to control for the absence of aerobic growth. Processing of fecal samples. The fecal samples were mixed and diluted in two steps. A sterile cotton swab was rotated in the center of the sample and was mixed in 4.5 ml of prereduced PYG. From this solution, 0.5 ml was further suspended in 4.5 ml of PYG. From the bacterial suspension thus obtained, samples of 0.1 ml were rapidly applied onto each of nine PDM agar plates with different antimicrobial agents and gentamicin as described earlier and on two control plates, aerobic and anaerobic, and after further dilution (1:0), a second anaerobic control plate was also included. Microbiological analysis. After incubation in anaerobic jars (GasPak) at 37 C for 48 h, the total number of anaerobic colonies growing on each control plate was counted. The resistant microorganisms growing on the antimicrobial plates were enumerated, isolated in pure cultures, and identified by morphological, gas chromatographic, and biochemical tests (14). As a control, all strains isolated were also incubated aerobically, and the strains which grew were disregarded. The MICs of the nine different antimicrobial agents for each strain were determined by the agar dilution method. A final inoculum of 5 to 6 CFU/ml prepared by dilution of a fresh agar culture was applied to the agar plates with a Steers replicator. The agar plates were incubated anaerobically at 37 C for 48 h. The MIC was defined as the lowest concentration which inhibited the growth of microorganisms on the ANTIMICROB. AGENTS CHEMOTHER. agar plates. The control strains used were Bacteroides fragilis NCTC 9343 and Clostndium perfringens ATCC Statistical methods. The results were analyzed by Student's t test, the chi-square test, and Kolmogorov Smirnov tests. RESULTS Frequency of resistant strains from saliva samples. No anaerobic strains resistant to the antimicrobial agents tested were isolated from the saliva samples of patients in any of the three groups. Frequency of resistant strains from fecal samples. Seventy percent of the patients harbored resistant anaerobic strains in their fecal samples. Two resistant strains or more per fecal sample were isolated from 37% of the patients, and three or more resistant strains were found in 15% of the patients. A total of 194 resistant strains were isolated. In the outpatient group (group A), 41 of the patients carried resistant strains; 34 of the patients in the hospitalized group without antimicrobial treatment (group B) and 31 of the patients in the hospitalized group with antimicrobial treatment (group C) harbored resistant strains. There was no statistically significant difference between the three patient groups in the prevalence of resistant strains or the distribution of patients with different numbers of strains. Differences in the resistance patterns between patient groups. All resistant strains were quantified in relation to the total number of anaerobic microorganisms in each patient. The mean value for each group was determined by comparing the relative frequency for each patient. There was no significant difference between the three patient groups according to the total amount of fecal anaerobic microorganisms. Patients in group A had 5.2% resistant strains (mean value) in their anaerobic fecal flora, patients in group B had 14.8% resistant strains, and patients in group C had 7.5% resistant strains in their fecal microflora. The resistant strains isolated were subdivided into <1% level and 21% level. For the outpatient group (group A), 36% of the strains were present at a relative frequency above the 1% level; for the hospitalized group without antimicrobial treatment (group B), 66% of the strains were present at greater than the 1% level; for the hospitalized group with antimicrobial treatment (group C), 61% of the strains were present at greater than the 1% level. The differences between group A and groups B and C were statistically significant in this respect (P < 0.001). Species prevalence of resistant strains in the fecal samples. Strains from the Bacteroides fragilis group dominated among the isolates (74%). The most commonly isolated bacteria were Bacteroides thetaiotaomicron (27%), Clostndium innocuum (24%), Bacteroides ovatus (19%), and Bacteroides uniformis (9%). The distributions of strains among the different patient groups are shown in Table 1. The outpatient group had a lower percentage of clostridial strains (17%) than either the hospital group without antimicrobial therapy (%) or the hospital group with antimicrobial therapy (21%), although the difference was not statistically significant. Distribution of resistance to different antimicrobial agents. Ampicillin was the antimicrobial agent to which most anaerobic strains showed resistance; this was followed by cefoxitin and cefuroxime (Table 2). No strains were found to be resistant to imipenem, chloramphenicol, or metronidazole. The MICs of the different antimicrobial agents for the strains Downloaded from on November 9, 18 by guest

3 VOL. 37, 1993 RESISTANCE IN HUMAN ANAEROBIC MICROFLORAS 1667 TABLE 1. Distribution of resistant anaerobic strains isolated from fecal samples from patients in groups A, B, and C Microorganism No. of strains/patient group A B C Total Bacteroides thetaiotaomicron Clostridium innocuum Bacteroides ovatus Bacteroides uniformis Bacteroides distasonis Bacteroides vulgatus Bacteroides fragilis Bacteroides caccae Bacteroides spp Prevotella melaninogenicus Prevotella eggerthii Prevotella oris Clostridium ramosum Prevotella bivius Prevotella loeschii Clostridium perfringens Clostridium sartagoforum Clostridium spp Clostridium subterminale Total isolated from the three groups of patients are shown in Fig. 1. Nine strains from the B. fragilis group (mostly B. distasonis and B. fragilis) were found to be highly resistant to ampicillin (MIC,.1,024,ug/ml) and were isolated from all three patient groups. Of 42 clostridial strains isolated, 41 were resistant to cefoxitin. There was no significant difference between the patient groups regarding the MICs for the strains isolated from the patients. Multiresistant strains in the fecal samples. Multiresistant strains were defined as those that were resistant to two or more antimicrobial agents. A total of 58 multiresistant strains were recovered in the fecal samples, with no significant difference between the three patients groups. B. thetaiotaomicron was the most commonly isolated species (Table 3). Multiresistant clostridia were found only in the hospitalized group treated with antimicrobial agents. The most common combination of multiresistance was ampicillin with cefuroxime (36 strains), while resistance against a betalactam agent and a non-beta-lactam agent occurred in 9 TABLE 2. Distribution of strains resistant to different antimicrobial agents in the three patient groups Antimicrobial agent No. of strains/patient group A B C Ampicillin Cefoxitin Cefuroxime Piperacillin Imipenem Doxycycline Clindamycin Chloramphenicol Metronidazole Total Uc z cn IL 0 m z 0 I AMPICILLIN El_~~~~~PIEACLI ~CFOII, PIPERA~~~~OXCYCLINE MINIMUM INHIBITORY CONCENTRATION gig/ml FIG. 1. Distribution of MICs of different antimicrobial agents for resistant strains. strains. No multiresistance involving imipenem, clindamycin, chloramphenicol, or metronidazole was found. Impact of time spent in hospital. When comparing the length of the hospital stay between the patients in the hospitalized groups, no difference regarding the prevalence of resistant strains or the number of bacteria was observed. Impact of antimicrobial treatment. The majority of patients in group C were treated with cefuroxime (36 patients). These patients were not specifically predisposed to an increase in the number of bacteria resistant to cefuroxime or to any beta-lactam agent in general. Neither was any statistically significant correlation found between patients receiving beta-lactam agents and the occurrence of beta-lactam resistance. Four of six patients receiving antimicrobial agents not belonging to the beta-lactam group harbored resistant strains. For patients who were treated with antimicrobial agents for 6 days or more, 9.9% of the anaerobic fecal microfloras of these patients were resistant to the antimicrobial agents tested, while for patients who received anti- Downloaded from on November 9, 18 by guest

4 1668 STARK ET AL. TABLE 3. Distribution of multiresistant anaerobic strains isolated from the fecal samples of 150 patients Bacterial species No. strains of Bacteroides thetaiotaomicron Bacteroides ovatus... 9 Bacteroides vulgatus Bacteroides uniformis... 7 Bacteroides distasonis... 5 Clostridium innocuum... 2 Bacteroides caccae Bacteroides fragilis Prevotella loeschii... 1 Prevotella melaninogenicus... 1 microbial treatment for a shorter period of time (<6 days), 5.8% of their fecal anaerobic microfloras were resistant. Patients treated for 6 days or more had an average of 1.6 resistant strains each, while patients treated for less than 6 days had a mean number of 0.87 resistant strains each (P < 0.05). DISCUSSION Anaerobic infections often originate from microorganisms from the patient's own microflora, and many antimicrobial agents that are active against these organisms are now available. However, an increasing number of treatment failures caused by anaerobic oacteria that are resistant to antimicrobial agents have been reported (3, 15). The results of the present study show that the frequency of resistant anaerobic microorganisms in the oropharyngeal tract is low in Sweden. This is in accordance with a study by Heimdahl et al. (), who investigated the occurrence of 1-lactamaseproducing Bacteroides species in the oral cavity in relation to penicillin therapy. Only a few beta-lactam-resistant Bacteroides strains were isolated from saliva samples in that study, and most patients harboring resistant strains had recently been treated with penicillin or ampicillin. The breakpoints of penicillin and ampicillin used in that study were.4,ug/ml; compare this with a breakpoint of 232,ug/ml for ampicillin in the present study. Bacteroides species are the most common pathogens in oral infections, and most strains are susceptible to clindamycin, metronidazole, and chloramphenicol (4,, 11). In the current study, the prevalence of patients with resistant anaerobic strains in their intestinal tracts was high (70%), with no significant difference between the three patient groups. The results of the present study show that although outpatients seem to have a higher number of resistant strains per person, the relative amount of resistant anaerobic bacteria in feces is lower in outpatients compared with that in hospitalized patients. In the outpatient group, one-third of the resistant strains made up more than 1% of the total anaerobic microflora, while in both hospitalized groups, two-thirds of the resistant strains constituted more than 1% of the total anaerobic fecal flora. Strains from the B. fragilis group were isolated most frequently, as has been reported previously (1, 3, 12). B. thetaiotaomicron and B. ovatus were the most commonly isolated members of the B. fragilis group. In previous studies, B. ovatus and then B. fragilis were the most frequently isolated anaerobic resistant strains from intestinal microfloras (1, 12). The antimicrobial susceptibility of the B. fragilis group in the present study ANTIMICROB. AGENTS CHEMOTHER. correlates well with those found in recent investigations in Canada and Europe (12, 16). The known mechanisms of resistance to beta-lactam antibiotics in anaerobic bacteria are elaboration of,3-lactamases, which inactivate the agent; alteration of the number or type of penicillin-binding proteins, which affects the affinity of the proteins for the antibiotics; and blocked penetration of the agent into the active site via alteration of the bacterial outer membrane porins (7, ). The most important factor in beta-lactam resistance appears to be the production of P-lactamases, which have been found in various Bacteroides, Fusobacterium, and Clostndium species (15). Thus, resistant anaerobic species in the normal microflora may play a role as indirect pathogens because of their P-lactamase production. Resistance to ampicillin, cefoxitin, and cefuroxime were often found in the fecal isolates. The relative percentage of strains resistant to ampicillin was higher in the hospitalized group receiving antimicrobial treatment than in the other two patient groups, although the difference was not statistically significant. Levy et al. (13) observed a statistically significant increase in the number of strains resistant to ampicillin among hospitalized patients with a recent history of unspecified antimicrobial treatment. A distinct correlation between local drug consumption and prevalence of resistant aerobic and anaerobic fecal microorganisms has been reported for ampicillin and doxycycline (12, 13). Resistance to cefoxitin occurred at the same frequency as resistance to ampicillin and cefuroxime, which is notable, since cefoxitin has generally been considered effective against species of the B. fragilis group. These findings are in accordance with those of Bourgault et al. (2), who reported that resistance to cefoxitin among the B. fragilis group in Canada has increased from 2 to 26% over the past 6 years. The resistance mechanism for cefoxitin is still poorly understood, but Piddock and Wise (17) have shown that resistant strains from the B. fragilis group have altered outer membrane porins. Resistance to carbapenems such as imipenem is very rare, although,b-lactamase-producing B. fragilis strains resistant to imipenem have been described (5, 9). The increased use of cefuroxime and metronidazole has not been correlated with the emergence of drug-resistant aerobic or anaerobic intestinal bacteria (12, 13). Since the most common drug regimen in the present study was cefuroxime, which was often used in combination with metronidazole, it is not surprising that no major differences between the hospitalized patient groups were found. However, patients who had antimicrobial treatment for 6 days or more had a significantly increased number of resistant anaerobic strains in their fecal microfloras compared with the numbers in patients who were treated for shorter periods of time. Patients who had been treated in the hospital for at least 6 days (groups B and C) had a significantly higher relative number of resistant microorganisms in their anaerobic intestinal microfloras compared with the numbers in outpatients. These results correlate well with those from the study by Levy et al. (13), in which an increased percentage of the total microfloras of hospitalized patients was resistant. This may be a result of the hospital stay, with large numbers of resistance determinants being present in strains in the environment, or it may be related to the health status of the patient. There are many problems involved in correlating in vitro susceptibility results with clinical success or failure in individual cases. Appropriate surgical manipulations, the microenvironment at the site of infection, host defense factors, the age and health of the patient, and the in vitro Downloaded from on November 9, 18 by guest

5 VOL. 37, 1993 RESISTANCE IN HUMAN ANAEROBIC MICROFLORAS 1669 susceptibilities of the causative microorganisms are all important factors that have a significant impact on the outcome (8, 21). In conclusion, the anaerobic intestinal microflora contains a large number of resistant anaerobic bacteria that mainly belong to the B. fragilis group. It seems that hospitalization or intake of antimicrobial agents promotes an increase in the relative number of resistant anaerobic microorganisms isolated from feces. REFERENCES 1. Andaker, L., P.-A. Kling, and L. G. Burman Antibiotic consumption and faecal bacterial susceptibility in surgical inpatients. Acta Chir. Scand. 153: Bourgault, A.-M., F. Lamothe, D. J. Hoban, M. T. Dalton, P. C. Kibsey, G. Harding, J. A. Smith, D. E. Low, and H. Gilbert Survey of Bacteroides fragilis group susceptibility patterns in Canada. Antimicrob. Agents Chemother. 36: Brook, I Anaerobic bacterial bacteremia: 12-year experience in two military hospitals. J. Infect. Dis. 160: Crook, D. W., G. J. Cuchural, Jr., N. V. Jacobus, and F. P. Tally Antimicrobial resistance in oral and colonic bacteroides. Scand. J. Infect. Dis. Suppl. 57: Cuchural, G. J., Jr., M. H. Malamy, and F. P. Tally ,-lactamase-mediated imipenem resistance in Bacteroides fragilis. Antimicrob. Agents Chemother. : Ellner, P. D., D. J. Fink, H. C. Neu, and M. F. Parry Epidemiologic factors affecting antimicrobial resistance of common bacterial isolates. J. Clin. Microbiol. 25: Finegold, S. M Mechanisms of resistance in anaerobes and new developments in testing. Diagn. Microbiol. Infect. Dis. 12: Finegold, S. M Clinical relevance of antimicrobial susceptibility testing. Eur. J. Microbiol. Infect. Dis. 11: Hedberg, M., C. Edlund, L. Lindquist, M. Rylander, and C. E. Nord Purification and characterisation of an imipenem hydrolysing metallo-beta-lactamase from Bacteroides fragilis. J. Antimicrob. Chemother. 29: Heimdahl, A., L. Konow, and C. E. Nord Beta-lactamaseproducing Bacteroides spp in the oral cavity in relation to penicillin therapy. J. Antimicrob. Chemother. 8: Heimdahl, A., and C. E. Nord Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man. Scand. J. Infect. Dis. 11: Kling, P.-A., R. Ostensson, S. Granstrom, and L. G. Burman A 7-year survey of drug resistance in aerobic and anaerobic fecal bacteria of surgical inpatients: clinical relevance and relation to local antibiotic consumption. Scand. J. Infect. Dis. 21: Levy, S. B., B. Marshall, S. Schluederberg, D. Rowse, and J. Davis High frequency of antimicrobial resistance in human fecal flora. Antimicrob. Agents Chemother. 32: Murray, P. R., and D. M. Citron General processing of specimens for anaerobic bacteria, p In A. Balows, W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C. 15. Nord, C. E., and M. Hedberg Resistance to betalactam antibiotics in anaerobic bacteria. Rev. Infect. Dis. 12(Suppl. 2): Phillips, I., A. King, C. E. Nord, and B. Hoffstedt. Antibiotic sensitivity of the Bacteroides fragilis group in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 11: Piddock, L. J. V., and R. Wise Cefoxitin resistance in Bacteroides species: evidence indicating two mechanisms causing decreased susceptibility. J. Antimicrob. Chemother. 19: Shaw, E. J., N. Datta, G. Jones, F. M. Marr, and W. J. B. Froud Effect of stay in hospital and oral chemotherapy on the antibiotic sensitivity of bowel coliforms. J. Hyg. Camb. 71: Sjostedt, S., P. Levin, L. Kager, A.-S. Malmborg, and U. Bergman Hospital and catchment area antibiotic utilization and bacterial sensitivity in primary infections following gastric surgery in Huddinge, Sweden. Eur. J. Clin. Pharmacol. 39: Tally, F. P., G. J. Cuchural, Jr., and M. H. Malamy Mechanisms of resistance and resistance transfer in anaerobic bacteria: factors influencing antimicrobial therapy. Rev. Infect. Dis. 6(Suppl. 1): Wexler, H Susceptibility testing of anaerobic bacteria: myth, magic, or method? Clin. Microbiol. Rev. 4: Downloaded from on November 9, 18 by guest

ECOLOGICAL IMPACT OF NARROW SPECTRUM ANTIMICROBIAL AGENTS COMPARED TO BROAD SPECTRUM AGENTS ON THE HUMAN INTESTINAL MICROFLORA CARL ERIK NORD

ECOLOGICAL IMPACT OF NARROW SPECTRUM ANTIMICROBIAL AGENTS COMPARED TO BROAD SPECTRUM AGENTS ON THE HUMAN INTESTINAL MICROFLORA CARL ERIK NORD Old Herborn University Seminar Monograph 3: Consequences of antimicrobial therapy for the composition of the microflora of the digestive tract. Editors: Carl Erik Nord, Peter J. Heidt, Volker Rusch, and

More information

Multicenter Study of In Vitro Susceptibility of the Bacteroides fragilis Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996

Multicenter Study of In Vitro Susceptibility of the Bacteroides fragilis Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 1999, p. 2417 2422 Vol. 43, No. 10 0066-4804/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Multicenter Study of In Vitro

More information

on February 12, 2018 by guest

on February 12, 2018 by guest AAC Accepted Manuscript Posted Online 12 February 2018 Antimicrob. Agents Chemother. doi:10.1128/aac.00047-18 Copyright 2018 Stapert et al. This is an open-access article distributed under the terms of

More information

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to

More information

Ciprofloxacin, Enoxacin, and Ofloxacin against Aerobic and

Ciprofloxacin, Enoxacin, and Ofloxacin against Aerobic and ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1988, p. 1143-1148 Vol., No. 8 0066-4804/88/081143-06$00/0 Copyright 1988, American Society for Microbiology Comparative Activities of, Amoxicillin-Clavulanic

More information

Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece

Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece Journal of Antimicrobial Chemotherapy (2008) 62, 137 141 doi:10.1093/jac/dkn134 Advance Access publication 1 April 2008 Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in

More information

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER University of Minnesota Health University of Minnesota Medical Center University of Minnesota Masonic Children s Hospital May 2017 Printed herein are

More information

against Clinical Isolates of Gram-Positive Bacteria

against Clinical Isolates of Gram-Positive Bacteria ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,

More information

Lessons Learned from the Anaerobe Survey: Historical Perspective and Review of the Most Recent Data ( )

Lessons Learned from the Anaerobe Survey: Historical Perspective and Review of the Most Recent Data ( ) SUPPLEMENT ARTICLE Lessons Learned from the Anaerobe Survey: Historical Perspective and Review of the Most Recent Data (2005 2007) David R. Snydman, 1,2 Nilda V. Jacobus, 1 Laura A. McDermott, 1 Yoav Golan,

More information

Clindamycin versus Phenoxymethylpenicillin in the Treatment of Acute Orofacial Infections

Clindamycin versus Phenoxymethylpenicillin in the Treatment of Acute Orofacial Infections Article Vol. 11. No. 12 1129 Eur. J. Clin, Microbiol. Infect. Dis., December 1992, p. 1129-1136 0934-9723/92/12 01129-07 $3.00/0 Clindamycin versus Phenoxymethylpenicillin in the Treatment of Acute Orofacial

More information

Effect of Lactobacillus F19 on the emergence of antibioticresistant microorganisms in the intestinal microflora

Effect of Lactobacillus F19 on the emergence of antibioticresistant microorganisms in the intestinal microflora Journal of Antimicrobial Chemotherapy (2004) 54, 791 797 DOI: 10.1093/jac/dkh406 Advance Access publication 25 August 2004 Effect of Lactobacillus F19 on the emergence of antibioticresistant microorganisms

More information

Should we test Clostridium difficile for antimicrobial resistance? by author

Should we test Clostridium difficile for antimicrobial resistance? by author Should we test Clostridium difficile for antimicrobial resistance? Paola Mastrantonio Department of Infectious Diseases Istituto Superiore di Sanità, Rome,Italy Clostridium difficile infection (CDI) (first

More information

Anaerobe bakterier og resistens. Ulrik Stenz Justesen Klinisk Mikrobiologisk Afdeling Odense Universitetshospital Odense, Denmark

Anaerobe bakterier og resistens. Ulrik Stenz Justesen Klinisk Mikrobiologisk Afdeling Odense Universitetshospital Odense, Denmark Anaerobe bakterier og resistens Ulrik Stenz Justesen Klinisk Mikrobiologisk Afdeling Odense Universitetshospital Odense, Denmark Programme anaerobic bacteria Carbapenem and metronidazole resistance New

More information

Susceptibility Testing of Anaerobic Bacteria: Evaluation of the Redesigned (Version 96) biomérieux ATB ANA Device

Susceptibility Testing of Anaerobic Bacteria: Evaluation of the Redesigned (Version 96) biomérieux ATB ANA Device JOURNAL OF CLINICAL MICROBIOLOGY, June 1999, p. 1824 1828 Vol. 37, No. 6 0095-1137/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Susceptibility Testing of Anaerobic

More information

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose 2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility

More information

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria

More information

Effects of Minocycline and Other Antibiotics on Fusobacterium necrophorum Infections in Mice

Effects of Minocycline and Other Antibiotics on Fusobacterium necrophorum Infections in Mice ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1975, p. 421-425 Copyright 0 1975 American Society for Microbiology Vol. 7, No. 4 Printed in U.S.A. Effects of Minocycline and Other s on Fusobacterium necrophorum

More information

Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy

Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy Journal of Antimicrobial Chemotherapy (2004) 53, Suppl. S2, ii29 ii36 DOI: 10.1093/jac/dkh201 Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem

More information

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2. AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony

More information

Antimicrobial Susceptibility of Clinical Isolates of Bacteroides fragilis Group Organisms Recovered from 2009 to 2012 in a Korean Hospital

Antimicrobial Susceptibility of Clinical Isolates of Bacteroides fragilis Group Organisms Recovered from 2009 to 2012 in a Korean Hospital Original Article Clinical Microbiology Ann Lab Med 2015;35:94-98 http://dx.doi.org/10.3343/alm.2015.35.1.94 ISSN 2234-3806 eissn 2234-3814 Antimicrobial Susceptibility of Clinical Isolates of Bacteroides

More information

Effect of dalbavancin on the normal intestinal microflora

Effect of dalbavancin on the normal intestinal microflora Journal of Antimicrobial Chemotherapy (00), 1 doi:10.109/jac/dkl1 Advance Access publication 1 July 00 Effect of dalbavancin on the normal intestinal microflora Carl Erik Nord*, Gundars Rasmanis and Elisabeth

More information

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production

More information

Susceptibility of the Bacteroides fragilis Group in the United

Susceptibility of the Bacteroides fragilis Group in the United ANTIMICROBIAL AGENTS AND CHEMOTHERPY, Apr. 1983, p. 536-540 0066-4804/83/040536-05$02.0O/0 Copyright C 1983, American Society for Microbiology Vol. 23, No. 4 Susceptibility of the Bacteroides fragilis

More information

What s new in EUCAST methods?

What s new in EUCAST methods? What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests

More information

ANTI-ANAEROBIC ACTIVITIES OF SULOPENEM COMPARED TO SIX OTHER. Departments of Pathology, Hershey Medical Center, Hershey, PA 17033

ANTI-ANAEROBIC ACTIVITIES OF SULOPENEM COMPARED TO SIX OTHER. Departments of Pathology, Hershey Medical Center, Hershey, PA 17033 AAC Accepts, published online ahead of print on 17 February 2009 Antimicrob. Agents Chemother. doi:10.1128/aac.01557-08 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions.

More information

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services 2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens

More information

Chapter Anaerobic infections (individual fields): intraperitoneal infections (acute peritonitis, hepatobiliary infections, etc.

Chapter Anaerobic infections (individual fields): intraperitoneal infections (acute peritonitis, hepatobiliary infections, etc. J Infect Chemother (2011) 17 (Suppl 1):84 91 DOI 10.1007/s10156-010-0146-5 GUIDELINES Chapter 2-5-4. Anaerobic infections (individual fields): intraperitoneal infections (acute peritonitis, hepatobiliary

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Anaerobic Bacteria in Intra-Abdominal Infections and Bacteremia Maria Hedberg, Umeå University, Umeå, Sweden Anaerobic Bacteria: Next Generation Technology Meets Anaerobic Diagnostics ESCMID Postgraduate

More information

R-factor mediated trimethoprim resistance: result of two three-month clinical surveys

R-factor mediated trimethoprim resistance: result of two three-month clinical surveys Journal of Clinical Pathology, 1978, 31, 850-854 R-factor mediated trimethoprim resistance: result of two three-month clinical surveys S. G. B. AMYES1, A. M. EMMERSON2, AND J. T. SMITH3 From the 'Department

More information

EUCAST recommended strains for internal quality control

EUCAST recommended strains for internal quality control EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC

More information

PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996

PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996 PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 996 November 996 by Maggie Brett Antibiotic Reference Laboratory ESR Communicable Disease Centre Porirua CONTENTS Page SUMMARY

More information

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose 2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility

More information

Tel: Fax:

Tel: Fax: CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.

More information

Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents

Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents Journal of Antimicrobial Chemotherapy (2004) 53, 1039 1044 DOI: 10.1093/jac/dkh248 Advance Access publication 5 May 2004 Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The

More information

Ecological impact of the des-f(6)-quinolone, BMS , on the normal intestinal microflora C. E. Nord 1, D. A. Gajjar 2 and D. M.

Ecological impact of the des-f(6)-quinolone, BMS , on the normal intestinal microflora C. E. Nord 1, D. A. Gajjar 2 and D. M. ORIGINAL ARTICLE Ecological impact of the des-f(6)-quinolone, BMS-284756, on the normal intestinal microflora C. E. Nord 1, D. A. Gajjar 2 and D. M. Grasela 2 1 Department of Microbiology, Pathology and

More information

Resistance pattern of anaerobic bacteria isolated in a general hospital during a two-year period

Resistance pattern of anaerobic bacteria isolated in a general hospital during a two-year period Journal of Antimicrobial Chemotherapy (9), Supp. D, 9 6 Resistance pattern of anaerobic bacteria isolated in a general hospital during a two-year period J. F. Acar, F. W. Goldstein, M. D. Kitzis and M.

More information

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

More information

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. C. difficile rarely causes problems, either in healthy adults or in infants.

More information

Principles of Antimicrobial therapy

Principles of Antimicrobial therapy Principles of Antimicrobial therapy Laith Mohammed Abbas Al-Huseini M.B.Ch.B., M.Sc, M.Res, Ph.D Department of Pharmacology and Therapeutics Antimicrobial agents are chemical substances that can kill or

More information

RELIABLE AND REALISTIC APPROACH TO SENSITIVITY TESTING

RELIABLE AND REALISTIC APPROACH TO SENSITIVITY TESTING RELIABLE AND REALISTIC APPROACH TO SENSITIVITY TESTING Pages with reference to book, From 94 To 97 S. Hafiz, N. Lyall, S. Punjwani, Shahida Q. Zaidi ( Department of Microbiology, The Aga Khan University

More information

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Introduction to Chemotherapeutic Agents Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Antimicrobial Agents Substances that kill bacteria without harming the host.

More information

Patterns of Susceptibility to Fluoroquinolones Among Anaerobic Bacterial Isolates in the United States

Patterns of Susceptibility to Fluoroquinolones Among Anaerobic Bacterial Isolates in the United States S377 Patterns of Susceptibility to Fluoroquinolones Among Anaerobic Bacterial Isolates in the United States Ellie J. C. Goldstein From R. M. Alden Research Laboratory, Santa Monica Hospital Medical Center,

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Reference Number: CP.HNMC.24 Effective Date: 07.01.17 Last Review Date: 02.18 Line of Business: Medicaid - HNMC Revision Log See Important Reminder at the end of this policy for important

More information

Secondary peritonitis

Secondary peritonitis Secondary peritonitis Caused by spillage of gastrointestinal microorganisms into the peritoneal cavity secondary to loss of the integrity of the mucosal barriers Etiology: perforation of peptic ulcer traumatic

More information

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information

More information

Intrinsic, implied and default resistance

Intrinsic, implied and default resistance Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been

More information

Quantitative Study of Antibiotic-Induced Susceptibility to

Quantitative Study of Antibiotic-Induced Susceptibility to ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 199, p. 1348-1353 66-484/9/71348-6$2./ Copyright 199, American Society for Microbiology Vol. 34, No. 7 Quantitative Study of Antibiotic-Induced Susceptibility

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton

More information

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Routine internal quality control as recommended by EUCAST Version 3.1, valid from Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus

More information

Piperacillin-Tazobactam, and Cefoxitin

Piperacillin-Tazobactam, and Cefoxitin ANTiMICROBLAL AGENTS AND CHEMOTHERAPY, Aug. 1993, p. 1649-1654 0066-4804/93/081649-06$00/0 Copyright 1993, American Society for Microbiology Vol. 37, No. 8 Susceptibilities of 428 Gram-Positive and -Negative

More information

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION VIRBAC CORPORATION USA Product Label http://www.vetdepot.com P.O. BOX 162059, FORT WORTH, TX, 76161 Telephone: 817-831-5030 Order Desk: 800-338-3659 Fax: 817-831-8327 Website: www.virbacvet.com CLINTABS

More information

Version 1.01 (01/10/2016)

Version 1.01 (01/10/2016) CHN58: ANTIMICROBIAL SUSCEPTIBILITY TESTING (CLSI) 1.0 PURPOSE / INTRODUCTION: 1.1 Introduction Antimicrobial susceptibility tests are performed in order to determine whether a pathogen is likely to be

More information

Original Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.**

Original Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.** Original Article In Vitro Activity of Cefminox and Other β-lactam Antibiotics Against Clinical Isolates of Extended- Spectrum-β-lactamase-Producing Klebsiella pneumoniae and Escherichia coli Ratri Hortiwakul,

More information

Antimicrobial Susceptibility Testing: The Basics

Antimicrobial Susceptibility Testing: The Basics Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories

More information

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory

More information

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Letter to the Editor Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Mohammad Rahbar, PhD; Massoud Hajia, PhD

More information

.'URRENT THERAPEUTIC RESEA. VOLUME 66, NUMBER 3, MAY/JuNE 2005

.'URRENT THERAPEUTIC RESEA. VOLUME 66, NUMBER 3, MAY/JuNE 2005 .'URRENT THERAPEUTIC RESEA VOLUME 66, NUMBER 3, MAY/JuNE 2005 Efficacy of Moxifloxacin Monotherapy Versus Gatifloxacin Monotherapy, Piperacillin- Tazobactam Combination Therapy, and Clindamycin Plus Gentamicin

More information

SESSION XVI NEW ANTIBIOTICS

SESSION XVI NEW ANTIBIOTICS SESSION XVI NEW ANTIBIOTICS New Antibiotics to Treat Anaerobic Infections 2 Goldstein, E.J.C.;* Citron, D.M. Antibiotic Pharmacodynamics 3 Stein, G.E.* Targeting Selenium Metabolism in Stickland Fermentors:

More information

Antibacterial susceptibility testing

Antibacterial susceptibility testing Antibiotics: Antil susceptibility testing are natural chemical substances produced by certain groups of microorganisms (fungi, ) that inhibit the growth of or kill the other that cause infection. Several

More information

Enterobacter aerogenes

Enterobacter aerogenes Enterobacter aerogenes Enterobacter sp. Enterobacter sp. Species: Enterobacter aerogenes Enterobacter agglomerans Enterobacter cloacae causes UTI, enterotoxigenic Often found in the normal intestinal flora,

More information

Evaluation of the BIOGRAM Antimicrobial Susceptibility Test System

Evaluation of the BIOGRAM Antimicrobial Susceptibility Test System JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1985, p. 793-798 0095-1137/85/110793-06$02.00/0 Copyright 1985, American Society for Microbiology Vol. 22, No. 5 Evaluation of the BIOGRAM Antimicrobial Susceptibility

More information

Mili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh

Mili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh Detection of extended spectrum beta-lactamase producing Gram-negative organisms: hospital prevalence and comparison of double disc synergy and E-test methods Mili Rani Saha and Sanya Tahmina Jhora Original

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01

More information

Medicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!

Medicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck! Medicinal Chemistry 561P 2 st hour Examination May 6, 2013 NAME: KEY Good Luck! 2 MDCH 561P Exam 2 May 6, 2013 Name: KEY Grade: Fill in your scantron with the best choice for the questions below: 1. Which

More information

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.

More information

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1 Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali Lec 1 28 Oct 2018 References Lippincott s IIIustrated Reviews / Pharmacology 6 th Edition Katzung and Trevor s Pharmacology / Examination

More information

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase

More information

Antibiotic Updates: Part II

Antibiotic Updates: Part II Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures

More information

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic

More information

AAC Revised. Activity of a Novel Cyclic Lipopeptide, CB-183,315 Against Resistant Clostridium difficile

AAC Revised. Activity of a Novel Cyclic Lipopeptide, CB-183,315 Against Resistant Clostridium difficile AAC Accepts, published online ahead of print on 5 March 2012 Antimicrob. Agents Chemother. doi:10.1128/aac.06257-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 AAC06257-11

More information

Antimicrobial Pharmacodynamics

Antimicrobial Pharmacodynamics Antimicrobial Pharmacodynamics November 28, 2007 George P. Allen, Pharm.D. Assistant Professor, Pharmacy Practice OSU College of Pharmacy at OHSU Objectives Become familiar with PD parameters what they

More information

Chapter Anaerobic infections (individual fields): prevention and treatment of postoperative infections

Chapter Anaerobic infections (individual fields): prevention and treatment of postoperative infections J Infect Chemother (2011) 17 (Suppl 1):62 66 DOI 10.1007/s10156-010-0141-x GUIDELINES Chapter 2-5-1. Anaerobic infections (individual fields): prevention and treatment of postoperative infections Ó Japanese

More information

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 The β- Lactam Antibiotics Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Penicillins. Cephalosporins. Carbapenems. Monobactams. The β- Lactam Antibiotics 2 3 How

More information

Intra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018

Intra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018 Intra-Abdominal Infections Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018 Select guidelines Mazuski JE, et al. The Surgical Infection

More information

Susceptibility of Respiratory Tract Anaerobes to Orally Administered Penicillins and Cephalosporins

Susceptibility of Respiratory Tract Anaerobes to Orally Administered Penicillins and Cephalosporins ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 1976, p. 713-720 Copyright 0 1976 American Society for Microbiology Vol. 10, No. 4 Printed in U.S.A. Susceptibility of Respiratory Tract Anaerobes to Orally

More information

56 Clinical and Laboratory Standards Institute. All rights reserved.

56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research  ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Antibiotic Susceptibility Pattern of Pseudomonas Aeruginosa Isolated From Various Clinical

More information

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Juhee Ahn Department of Medical Biomaterials Engineering Kangwon National University October 23, 27 Antibiotic Development

More information

MICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ

MICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 2000, p. 1062 1066 Vol. 44, No. 4 0066-4804/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. In Vitro Activities of Daptomycin,

More information

Synergism Between Penicillin, Clindamycin, or Metronidazole and Gentamicin Against Species of the Bacteroides melaninogenicus and

Synergism Between Penicillin, Clindamycin, or Metronidazole and Gentamicin Against Species of the Bacteroides melaninogenicus and ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 1984, p. 71-77 0066-4804/84/010071-07$02.00/0 Copyright C 1984, American Society for Microbiology Vol. 25, No. 1 Synergism Between Penicillin, Clindamycin, or

More information

Brief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae

Brief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae Journal of Antimicrobial Chemotherapy (1997) 40, 105 108 Brief reports JAC Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae Andreas Pikis a *, Jacob A. Donkersloot

More information

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance Streptococcus pneumoniae Oxacillin µg as screen for beta-lactam resistance Version 6. June Streptococcus pneumoniae and zone diameter correlates The following histograms present inhibition zone diameter

More information

Burn Infection & Laboratory Diagnosis

Burn Infection & Laboratory Diagnosis Burn Infection & Laboratory Diagnosis Introduction Burns are one the most common forms of trauma. 2 million fires each years 1.2 million people with burn injuries 100000 hospitalization 5000 patients die

More information

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review (1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA

More information

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi Antibacterial therapy 1 د. حامد الزعبي Dr Hamed Al-Zoubi ILOs Principles and terms Different categories of antibiotics Spectrum of activity and mechanism of action Resistancs Antibacterial therapy What

More information

THERAPY OF ANAEROBIC INFECTIONS LUNG ABSCESS BRAIN ABSCESS

THERAPY OF ANAEROBIC INFECTIONS LUNG ABSCESS BRAIN ABSCESS THERAPY OF ANAEROBIC INFECTIONS Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu LUNG ABSCESS A lung abscess is a localized pus cavity in

More information

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد م. مادة االدوية المرحلة الثالثة م. غدير حاتم محمد 2017-2016 ANTIMICROBIAL DRUGS Antimicrobial drugs Lecture 1 Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease. Antimicrobial drugs:

More information

SELECT NEWS. Florfenicol Monograph: Injectable Therapy for Cattle

SELECT NEWS. Florfenicol Monograph: Injectable Therapy for Cattle SELECT NEWS Florfenicol Monograph: Injectable Therapy for Cattle Did you know that? Florfenicol is one of the most powerful antibiotics currently available in veterinary medicine with one of the lowest

More information

Antimicrobials & Resistance

Antimicrobials & Resistance Antimicrobials & Resistance History 1908, Paul Ehrlich - Arsenic compound Arsphenamine 1929, Alexander Fleming - Discovery of Penicillin 1935, Gerhard Domag - Discovery of the red dye Prontosil (sulfonamide)

More information

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain

More information

Sepsis is the most common cause of death in

Sepsis is the most common cause of death in ADDRESSING ANTIMICROBIAL RESISTANCE IN THE INTENSIVE CARE UNIT * John P. Quinn, MD ABSTRACT Two of the more common strategies for optimizing antimicrobial therapy in the intensive care unit (ICU) are antibiotic

More information

Antimicrobial Resistance and Prescribing

Antimicrobial Resistance and Prescribing Antimicrobial Resistance and Prescribing John Ferguson, Microbiology & Infectious Diseases, John Hunter Hospital, University of Newcastle, NSW, Australia M Med Part 1 updates UPNG 2017 Tw @mdjkf http://idmic.net

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/26062

More information

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014

More information

Bacteria Isolated from Clinical Specimens1

Bacteria Isolated from Clinical Specimens1 ANTMCROBAL AGENT AND CHEMOTHERAPY, Feb., p. 8-8 Copyright American ociety for Microbiology Vol., No. Printed in U..A. n Vitro Antimicrobial usceptibility of Anaerobic Bacteria solated from Clinical pecimens

More information

Antimicrobials. Antimicrobials

Antimicrobials. Antimicrobials Antimicrobials For more than 50 years, antibiotics have come to the rescue by routinely producing rapid and long-lasting miracle cures. However, from the beginning antibiotics have selected for resistance

More information

Chapter 12. Antimicrobial Therapy. Antibiotics 3/31/2010. Spectrum of antibiotics and targets

Chapter 12. Antimicrobial Therapy. Antibiotics 3/31/2010. Spectrum of antibiotics and targets Chapter 12 Topics: - Antimicrobial Therapy - Selective Toxicity - Survey of Antimicrobial Drug - Microbial Drug Resistance - Drug and Host Interaction Antimicrobial Therapy Ehrlich (1900 s) compound 606

More information